ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹731 Cr | ₹711 Cr | ₹688 Cr | ₹656 Cr | ₹633 Cr |
What is the latest Total Non-Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹731 Cr |
| Mar2024 | ₹711 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹656 Cr |
| Mar2021 | ₹633 Cr |
How is Total Non-Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹731 Cr | 2.79 | |
| Mar2024 | ₹711 Cr | 3.35 | |
| Mar2023 | ₹688 Cr | 4.98 | |
| Mar2022 | ₹656 Cr | 3.55 | |
| Mar2021 | ₹633 Cr | - | |
Compare Total Non-Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,491.3 Cr | -0.1% | 0.9% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -0.1% |
0.9% |
-17.7% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses